연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1267. Limited value and utility of breast MRI in patients undergoing breast-conserving cancer surgery.
Shin HC, Han W, Moon HG, Yom CK, Ahn SK, You JM, Kim JS, Chang JM, Cho N, Moon WK, Park IA, Noh DY.
Ann Surg Oncol. 2012 Aug;19(8):2572-9.
Link
1266. Nomogram for predicting positive resection margins after breast-conserving surgery.
Shin HC, Han W, Moon HG, Cho N, Moon WK, Park IA, Park SJ, Noh DY.
Breast Cancer Res Treat. 2012 Aug;134(3):1115-23.
Link
1265. Phloroglucinol exerts protective effects against oxidative stress?induced cell damage in SH-SY5Y cells.
Kim HS, Lee K, Kang KA, Lee NH, Hyun JW, Kim HS.
J Pharmacol Sci. 2012;119(2):186-92.
Link
1264. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
Hong SK, Hwang SM, Kim JE, Kim HK.
Blood Coagul Fibrinolysis. 2012 Dec;23(8):739-44. doi: 10.1097/MBC.0b013e328358e899.
Link
1263. Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in her2-positive metastatic breast cancer.
Han SW, Cha Y, Paquet A, Huang W, Weidler J, Lie Y, Sherwood T, Bates M, Haddad M, Park IH, Oh DY, Lee KS, Im SA, Bang YJ, Ro J, Kim TY.
PLoS One. 2012;7(7):e39943.
Link
1262. Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers.
Yun J, Song SH, Park J, Kim HP, Yoon YK, Lee KH, Han SW, Oh DY, Im SA, Bang YJ, Kim TY.
Lab Invest. 2012 Jul;92(7):1033-44.
Link
1261. Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody.
Kim JG, Kang MJ, Yoon YK, Kim HP, Park J, Song SH, Han SW, Park JW, Kang GH, Kang KW, Oh do Y, Im SA, Bang YJ, Yi EC, Kim TY.
PLoS One. 2012;7(3):e33322.
Link
1260. Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells.
Yoon YK, Kim HP, Song SH, Han SW, Oh do Y, Im SA, Bang YJ, Kim TY.
Cancer Lett. 2012 Mar;316(1):77-84.
Link
1259. Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.
Jang JY, Kim MK, Jeon YK, Joung YK, Park KD, Kim CW.
Exp Mol Med. 2012 Apr 30;44(4):251-9.
Link
1258. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.
Woo JK, Choi Y, Oh SH, Jeong JH, Choi DH, Seo HS, Kim CW.
Oncogene. 2012 Apr 26;31(17):2187-98.
Link